{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:56:34Z","timestamp":1794473794438,"version":"4.9.1"},"reference-count":57,"publisher":"American Association for Cancer Research (AACR)","issue":"15","funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Scholar Grant","award":["RSG-18-027-01-CSM"],"award-info":[{"award-number":["RSG-18-027-01-CSM"]}]},{"name":"NIH"},{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"crossref","award":["R01 AR070773"],"award-info":[{"award-number":["R01 AR070773"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"crossref","award":["R01 AR079171"],"award-info":[{"award-number":["R01 AR079171"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-18-1-0336"],"award-info":[{"award-number":["W81XWH-18-1-0336"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-18-1-0121"],"award-info":[{"award-number":["W81XWH-18-1-0121"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0795"],"award-info":[{"award-number":["W81XWH-20-1-0795"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0302"],"award-info":[{"award-number":["W81XWH-20-1-0302"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Sarcomas produce an abnormal extracellular matrix (ECM), which in turn provides instructive cues for cell growth and invasion. Neural EGF like-like molecule 1 (NELL1) is a secreted glycoprotein characterized by its nonneoplastic osteoinductive effects, yet it is highly expressed in skeletal sarcomas. Here, we show that genetic deletion of NELL1 markedly reduces invasive behavior across human osteosarcoma (OS) cell lines. NELL1 deletion resulted in reduced OS disease progression, inhibiting metastasis and improving survival in a xenograft mouse model. These observations were recapitulated with Nell1 conditional knockout in mouse models of p53\/Rb-driven sarcomagenesis, which reduced tumor frequency and extended tumor-free survival. Transcriptomic and phosphoproteomic analyses demonstrated that NELL1 loss skews the expression of matricellular proteins associated with reduced FAK signaling. Culturing NELL1 knockout sarcoma cells on wild-type OS-enriched matricellular proteins reversed the phenotypic and signaling changes induced by NELL1 deficiency. In sarcoma patients, high expression of NELL1 correlated with decreased overall survival. These findings in mouse and human models suggest that NELL1 expression alters the sarcoma ECM, thereby modulating cellular invasive potential and prognosis. Disruption of NELL1 signaling may represent a novel therapeutic approach to short-circuit sarcoma disease progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>NELL1 modulates the sarcoma matrisome to promote tumor growth, invasion, and metastasis, identifying the matrix-associated protein as an orchestrator of cell\u2013ECM interactions in sarcomagenesis and disease progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-22-0732","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T09:34:38Z","timestamp":1657618478000},"page":"2734-2747","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["NELL1 Regulates the Matrisome to Promote Osteosarcoma Progression"],"prefix":"10.1158","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5437-0208","authenticated-orcid":false,"given":"Qizhi","family":"Qin","sequence":"first","affiliation":[{"name":"1Department of Pathology, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Gomez-Salazar","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5856-5758","authenticated-orcid":false,"given":"Robert J.","family":"Tower","sequence":"additional","affiliation":[{"name":"2Department of Orthopaedics, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Chang","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4007-9476","authenticated-orcid":false,"given":"Carol D.","family":"Morris","sequence":"additional","affiliation":[{"name":"2Department of Orthopaedics, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward F.","family":"McCarthy","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Ting","sequence":"additional","affiliation":[{"name":"3Forsyth Institute, Cambridge, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9458-3985","authenticated-orcid":false,"given":"Xinli","family":"Zhang","sequence":"additional","affiliation":[{"name":"4Section of Orthodontics, Division of Growth and Development, School of Dentistry, University of California, Los Angeles, Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2002-622X","authenticated-orcid":false,"given":"Aaron W.","family":"James","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Johns Hopkins University, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"2025112417200394500_bib1","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.18632\/oncotarget.12548","article-title":"Advances in sarcoma diagnostics and treatment","volume":"8","author":"Dancsok","year":"2017","journal-title":"Oncotarget"},{"key":"2025112417200394500_bib2","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3390\/biomedicines9101315","article-title":"Liquid biopsies in sarcoma clinical practice: where do we stand?","volume":"9","author":"van der Laan","year":"2021","journal-title":"Biomedicines"},{"key":"2025112417200394500_bib3","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1158\/0008-5472.CAN-18-1984","article-title":"A feedback loop between hypoxia and matrix stress relaxation increases oxygen-axis migration and metastasis in sarcoma","volume":"79","author":"Lewis","year":"2019","journal-title":"Cancer Res"},{"key":"2025112417200394500_bib4","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1242\/jcs.023820","article-title":"The extracellular matrix at a glance","volume":"123","author":"Frantz","year":"2010","journal-title":"J Cell Sci"},{"key":"2025112417200394500_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.10.013","article-title":"Extracellular matrix component signaling in cancer","volume":"97","author":"Multhaupt","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"2025112417200394500_bib6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","article-title":"Matrix crosslinking forces tumor progression by enhancing integrin signaling","volume":"139","author":"Levental","year":"2009","journal-title":"Cell"},{"key":"2025112417200394500_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF02698042","article-title":"Naturally produced extracellular matrix inhibits growth rate and invasiveness of human osteosarcoma cancer cells","volume":"24","author":"Ivanov","year":"2007","journal-title":"Med Oncol"},{"key":"2025112417200394500_bib8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10571-015-0170-1","article-title":"Extracellular matrix glycoprotein-derived synthetic peptides differentially modulate glioma and sarcoma cell migration","volume":"35","author":"Brosicke","year":"2015","journal-title":"Cell Mol Neurobiol"},{"key":"2025112417200394500_bib9","doi-asserted-by":"crossref","first-page":"8190","DOI":"10.12659\/MSM.918048","article-title":"Marital status and survival in osteosarcoma patients: an analysis of the surveillance, epidemiology, and end results (SEER) database","volume":"25","author":"Qiu","year":"2019","journal-title":"Med Sci Monit"},{"key":"2025112417200394500_bib10","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s00264-019-04348-4","article-title":"Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End Results population-based study","volume":"43","author":"Song","year":"2019","journal-title":"Int Orthop"},{"key":"2025112417200394500_bib11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13046-020-01685-w","article-title":"The role of extracelluar matrix in osteosarcoma progression and metastasis","volume":"39","author":"Cui","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"2025112417200394500_bib12","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3892\/or.2016.4986","article-title":"Parathyroid hormone\/parathyroid hormone-related peptide regulate osteosarcoma cell functions: focus on the extracellular matrix (review)","volume":"36","author":"Nikitovic","year":"2016","journal-title":"Oncol Rep"},{"key":"2025112417200394500_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/PAT.0b013e328353447b","article-title":"Syndecan-4 and fibronectin in osteosarcoma","volume":"44","author":"Na","year":"2012","journal-title":"Pathology"},{"key":"2025112417200394500_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13046-021-01963-1","article-title":"The potential role of the extracellular matrix in the activity of trabectedin in UPS and L-sarcoma: evidences from a patient-derived primary culture case series in tridimensional and zebrafish models","volume":"40","author":"De Vita","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"2025112417200394500_bib15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ajpath.2017.11.018","article-title":"The effects of systemic therapy of PEGylated NEL-like protein 1 (NELL-1) on fracture healing in mice","volume":"188","author":"Tanjaya","year":"2018","journal-title":"Am J Pathol"},{"key":"2025112417200394500_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ajpath.2015.10.011","article-title":"Novel Wnt regulator NEL-like molecule-1 antagonizes adipogenesis and augments osteogenesis induced by bone morphogenetic protein 2","volume":"186","author":"Shen","year":"2016","journal-title":"Am J Pathol"},{"key":"2025112417200394500_bib17","doi-asserted-by":"crossref","first-page":"7362","DOI":"10.1038\/ncomms8362","article-title":"NELL-1 in the treatment of osteoporotic bone loss","volume":"6","author":"James","year":"2015","journal-title":"Nat Commun"},{"key":"2025112417200394500_bib18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1089\/ten.tea.2012.0042","article-title":"NELL-1 injection maintains long-bone quantity and quality in an ovariectomy-induced osteoporotic senile rat model","volume":"19","author":"Kwak","year":"2013","journal-title":"Tissue Eng Part A"},{"key":"2025112417200394500_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1359\/jbmr.1999.14.1.80","article-title":"Human NELL-1 expressed in unilateral coronal synostosis","volume":"14","author":"Ting","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2025112417200394500_bib20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/PRS.0b013e3181fed5ae","article-title":"Nell-1 enhances bone regeneration in a rat critical-sized femoral segmental defect model","volume":"127","author":"Li","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"2025112417200394500_bib21","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1089\/ten.tea.2015.0230","article-title":"Vertebral implantation of NELL-1 enhances bone formation in an osteoporotic sheep model","volume":"22","author":"James","year":"2016","journal-title":"Tissue Eng Part A"},{"key":"2025112417200394500_bib22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/hmg\/ddl053","article-title":"Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects","volume":"15","author":"Desai","year":"2006","journal-title":"Hum Mol Genet"},{"key":"2025112417200394500_bib23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.bbrc.2015.03.040","article-title":"NELL-1 expression in benign and malignant bone tumors","volume":"460","author":"Shen","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"2025112417200394500_bib24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/jbmr.3615","article-title":"Inactivation of Nell-1 in chondrocytes significantly impedes appendicular skeletogenesis","volume":"34","author":"Qi","year":"2019","journal-title":"J Bone Miner Res"},{"key":"2025112417200394500_bib25","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1038\/onc.2014.354","article-title":"The impact of osteoblastic differentiation on osteosarcomagenesis in the mouse","volume":"34","author":"Quist","year":"2015","journal-title":"Oncogene"},{"key":"2025112417200394500_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tvjl.2012.05.003","article-title":"PDGFs and PDGFRs in canine osteosarcoma: new targets for innovative therapeutic strategies in comparative oncology","volume":"195","author":"Maniscalco","year":"2013","journal-title":"Vet J"},{"key":"2025112417200394500_bib27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/stem.3108","article-title":"PDGFRalpha marks distinct perivascular populations with different osteogenic potential within adipose tissue","volume":"38","author":"Wang","year":"2020","journal-title":"Stem Cells"},{"key":"2025112417200394500_bib28","doi-asserted-by":"crossref","first-page":"e58990","DOI":"10.7554\/eLife.58990","article-title":"Lysosomal protein surface expression discriminates fat- from bone-forming human mesenchymal precursor cells","volume":"9","author":"Xu","year":"2020","journal-title":"Elife"},{"key":"2025112417200394500_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nprot.2008.221","article-title":"A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow","volume":"4","author":"Soleimani","year":"2009","journal-title":"Nat Protoc"},{"key":"2025112417200394500_bib30","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1158\/0008-5472.CAN-19-1764","article-title":"MAFB promotes cancer stemness and tumorigenesis in osteosarcoma through a Sox9-mediated positive feedback loop","volume":"80","author":"Chen","year":"2020","journal-title":"Cancer Res"},{"key":"2025112417200394500_bib31","doi-asserted-by":"crossref","first-page":"eaal5148","DOI":"10.1126\/scitranslmed.aal5148","article-title":"Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers","volume":"9","author":"Sun","year":"2017","journal-title":"Sci Transl Med"},{"key":"2025112417200394500_bib32","doi-asserted-by":"crossref","first-page":"e82875","DOI":"10.1371\/journal.pone.0082875","article-title":"Diffusion MRI and novel texture analysis in osteosarcoma xenotransplants predicts response to anti-checkpoint therapy","volume":"8","author":"Foroutan","year":"2013","journal-title":"PLoS One"},{"key":"2025112417200394500_bib33","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1073\/pnas.0805462105","article-title":"Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage","volume":"105","author":"Berman","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025112417200394500_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/ten.tea.2016.0537","article-title":"NELL-1, HMGB1, and CCN2 enhance migration and vasculogenesis, but not osteogenic differentiation compared to BMP2","volume":"24","author":"Fahmy-Garcia","year":"2018","journal-title":"Tissue Eng Part A"},{"key":"2025112417200394500_bib35","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1101\/gad.1656808","article-title":"Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease","volume":"22","author":"Walkley","year":"2008","journal-title":"Genes Dev"},{"key":"2025112417200394500_bib36","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/pr.2016.120","article-title":"A systematic review and meta-analysis of MDM2 polymorphisms in osteosarcoma susceptibility","volume":"80","author":"Bilbao-Aldaiturriaga","year":"2016","journal-title":"Pediatr Res"},{"key":"2025112417200394500_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3892\/or.2021.8086","article-title":"CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in patients with osteosarcoma","volume":"46","author":"Iwata","year":"2021","journal-title":"Oncol Rep"},{"key":"2025112417200394500_bib38","doi-asserted-by":"crossref","first-page":"11365","DOI":"10.1038\/srep11365","article-title":"CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma","volume":"5","author":"Gao","year":"2015","journal-title":"Sci Rep"},{"key":"2025112417200394500_bib39","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1089\/ten.tea.2012.0519","article-title":"BMP2-induced inflammation can be suppressed by the osteoinductive growth factor NELL-1","volume":"19","author":"Shen","year":"2013","journal-title":"Tissue Eng Part A"},{"key":"2025112417200394500_bib40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13046-015-0175-0","article-title":"Associations of chemo- and radio-resistant phenotypes with the gap junction, adhesion and extracellular matrix in a three-dimensional culture model of soft sarcoma","volume":"34","author":"Bai","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"2025112417200394500_bib41","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1074\/mcp.RA118.000596","article-title":"The Ewing sarcoma secretome and its response to activation of Wnt\/beta-catenin signaling","volume":"17","author":"Hawkins","year":"2018","journal-title":"Mol Cell Proteomics"},{"key":"2025112417200394500_bib42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fonc.2020.00076","article-title":"Carcinoma and sarcoma microenvironment at a glance: where we are","volume":"10","author":"Saggioro","year":"2020","journal-title":"Front Oncol"},{"key":"2025112417200394500_bib43","first-page":"437096","article-title":"The CCN family proteins: modulators of bone development and novel targets in bone-associated tumors","volume":"2014","author":"Chen","year":"2014","journal-title":"Biomed Res Int"},{"key":"2025112417200394500_bib44","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1159\/000495714","article-title":"Targeting CD44 by CRISPR-Cas9 in multi-drug resistant osteosarcoma cells","volume":"51","author":"Xiao","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"2025112417200394500_bib45","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1080\/14789450.2017.1394190","article-title":"Current status of proteomics of soft tissue sarcomas","volume":"14","author":"Kondo","year":"2017","journal-title":"Expert Rev Proteomics"},{"key":"2025112417200394500_bib46","doi-asserted-by":"crossref","first-page":"e29442","DOI":"10.1002\/pbc.29442","article-title":"Current approaches to management of bone sarcoma in adolescent and young adult patients","volume":"69","author":"Ingley","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"2025112417200394500_bib47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.joen.2015.08.024","article-title":"Nel-like molecule 1 contributes to the odontoblastic differentiation of human dental pulp cells","volume":"42","author":"Liu","year":"2016","journal-title":"J Endod"},{"key":"2025112417200394500_bib48","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1089\/ten.tea.2010.0705","article-title":"The Nell-1 growth factor stimulates bone formation by purified human perivascular cells","volume":"17","author":"Zhang","year":"2011","journal-title":"Tissue Eng Part A"},{"key":"2025112417200394500_bib49","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/cncr.22455","article-title":"Markers of angiogenesis and clinical features in patients with sarcoma","volume":"109","author":"DuBois","year":"2007","journal-title":"Cancer"},{"key":"2025112417200394500_bib50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fcell.2015.00004","article-title":"The regulation of MMP targeting to invadopodia during cancer metastasis","volume":"3","author":"Jacob","year":"2015","journal-title":"Front Cell Dev Biol"},{"key":"2025112417200394500_bib51","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/35036374","article-title":"Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis","volume":"2","author":"Bergers","year":"2000","journal-title":"Nat Cell Biol"},{"key":"2025112417200394500_bib52","doi-asserted-by":"crossref","first-page":"33086","DOI":"10.18632\/oncotarget.16526","article-title":"NELL1, whose high expression correlates with negative outcomes, has different methylation patterns in alveolar and embryonal rhabdomyosarcoma","volume":"8","author":"Tombolan","year":"2017","journal-title":"Oncotarget"},{"key":"2025112417200394500_bib53","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1158\/0008-5472.CAN-12-4033","article-title":"Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers","volume":"73","author":"Wu","year":"2013","journal-title":"Cancer Res"},{"key":"2025112417200394500_bib54","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.1038\/sj.onc.1210461","article-title":"Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma","volume":"26","author":"Jin","year":"2007","journal-title":"Oncogene"},{"key":"2025112417200394500_bib55","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/cas.12649","article-title":"Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma","volume":"106","author":"Nakamura","year":"2015","journal-title":"Cancer Sci"},{"key":"2025112417200394500_bib56","first-page":"1817","article-title":"Effect of NELL1 on lung cancer stemlike cell differentiation","volume":"41","author":"Zhai","year":"2019","journal-title":"Oncol Rep"},{"key":"2025112417200394500_bib57","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-22-0732\/3180082\/can-22-0732.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/82\/15\/2734\/3184333\/2734.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/82\/15\/2734\/3184333\/2734.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T22:20:21Z","timestamp":1764022821000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/82\/15\/2734\/707333\/NELL1-Regulates-the-Matrisome-to-Promote"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":57,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2022,6,14]]},"published-print":{"date-parts":[[2022,8,3]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-22-0732","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22431872.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22431866.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6514019.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6514019","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22431866","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22431872","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]}}}